Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-05-15

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.2bn reported value -19.4% vs Q4 2024
37positions
76.1%in top 10
4 new 4 added 7 reduced 4 sold out vs Q4 2024

Holdings, Q1 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $317.3m27.00% 27.00% UnchangedShares held: Q2 2024 8.5m, Q3 2024 8.5m, Q4 2024 8.5m, Q1 2025 8.5m
2 METSERA INC COM COM 3,750,662 $102.1m8.69% 8.69% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 3.8m
3 OCULAR THERAPEUTIX INC COM OCUL OCUL 12,762,462 $93.5m7.96% 7.96% UnchangedShares held: Q2 2024 12.8m, Q3 2024 12.8m, Q4 2024 12.8m, Q1 2025 12.8m
4 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 4,026,331 $79.2m6.74% 6.74% UnchangedShares held: Q2 2024 4.0m, Q3 2024 4.0m, Q4 2024 4.0m, Q1 2025 4.0m
5 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,703,985 $77.4m6.58% 6.58% AddedShares held: Q2 2024 6.2m, Q3 2024 6.2m, Q4 2024 6.2m, Q1 2025 6.7m +454.3k +454,254 7.3%
6 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,709 $52.3m4.45% 4.45% UnchangedShares held: Q2 2024 3.9m, Q3 2024 3.9m, Q4 2024 3.9m, Q1 2025 3.9m
7 PHARVARIS N V COM PHVS PHVS 3,112,720 $48.9m4.16% 4.16% ReducedShares held: Q2 2024 3.4m, Q3 2024 3.4m, Q4 2024 3.2m, Q1 2025 3.1m -107.4k -107,410 -3.3%
8 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 2,685,448 $43.3m3.69% 3.69% UnchangedShares held: Q2 2024 2.7m, Q3 2024 2.7m, Q4 2024 2.7m, Q1 2025 2.7m
9 ORUKA THERAPEUTICS INC COM ORKA ORKA 4,148,428 $42.6m3.62% 3.62% AddedShares held: Q2 2024 0, Q3 2024 3.1m, Q4 2024 3.3m, Q1 2025 4.1m +862.8k +862,808 26.3%
10 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 989,985 $37.5m3.19% 3.19% UnchangedShares held: Q2 2024 706.1k, Q3 2024 706.1k, Q4 2024 990.0k, Q1 2025 990.0k
11 COGENT BIOSCIENCES INC COM COGT COGT 5,684,411 $34.0m2.90% 2.90% UnchangedShares held: Q2 2024 5.7m, Q3 2024 5.7m, Q4 2024 5.7m, Q1 2025 5.7m
12 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,744,373 $31.6m2.69% 2.69% UnchangedShares held: Q2 2024 2.1m, Q3 2024 1.7m, Q4 2024 1.7m, Q1 2025 1.7m
13 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $22.7m1.93% 1.93% UnchangedShares held: Q2 2024 2.2m, Q3 2024 2.2m, Q4 2024 2.2m, Q1 2025 2.2m
14 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 1,051,518 $22.6m1.93% 1.93% AddedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 765.7k, Q1 2025 1.1m +285.8k +285,795 37.3%
15 ENGENE HOLDINGS INC COM COM 5,046,414 $22.6m1.92% 1.92% UnchangedShares held: Q2 2024 2.8m, Q3 2024 3.6m, Q4 2024 5.0m, Q1 2025 5.0m
16 ERASCA INC COM ERAS ERAS 16,216,216 $22.2m1.89% 1.89% UnchangedShares held: Q2 2024 16.2m, Q3 2024 16.2m, Q4 2024 16.2m, Q1 2025 16.2m
17 ORIC PHARMACEUTICALS INC COM ORIC ORIC 3,182,527 $17.8m1.51% 1.51% ReducedShares held: Q2 2024 4.4m, Q3 2024 4.4m, Q4 2024 4.4m, Q1 2025 3.2m -1.2m -1,212,000 -27.6%
18 UPSTREAM BIO INC COM UPB UPB 2,295,319 $14.0m1.20% 1.20% UnchangedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 2.3m, Q1 2025 2.3m
19 ASTRIA THERAPEUTICS INC COM CATB CATB 2,457,348 $13.1m1.12% 1.12% UnchangedShares held: Q2 2024 3.6m, Q3 2024 3.5m, Q4 2024 2.5m, Q1 2025 2.5m
20 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $10.4m0.89% 0.89% UnchangedShares held: Q2 2024 1.4m, Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 1.4m
21 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 2,481,400 $9.2m0.78% 0.78% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 2.5m
22 SAVARA INC COM SVRA SVRA 3,257,639 $9.0m0.77% 0.77% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 3.3m
23 ABIVAX SA SPONSORED ADS ABVX ABVX 1,345,780 $8.4m0.72% 0.72% UnchangedShares held: Q2 2024 1.3m, Q3 2024 1.3m, Q4 2024 1.3m, Q1 2025 1.3m
24 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 750,000 $7.7m0.66% 0.66% UnchangedShares held: Q2 2024 750.0k, Q3 2024 750.0k, Q4 2024 750.0k, Q1 2025 750.0k
25 SURROZEN INC COM NEW SRZN SRZN 632,931 $7.4m0.63% 0.63% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 632.9k
26 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 5,023,166 $6.5m0.55% 0.55% AddedShares held: Q2 2024 6.0m, Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 5.0m +3.0m +3,000,000 148.3%
27 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 1,609,569 $4.8m0.41% 0.41% UnchangedShares held: Q2 2024 0, Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m
28 TREVI THERAPEUTICS INC COM TRVI TRVI 615,506 $3.9m0.33% 0.33% ReducedShares held: Q2 2024 3.4m, Q3 2024 3.4m, Q4 2024 1.3m, Q1 2025 615.5k -651.0k -650,951 -51.4%
29 APPLIED THERAPEUTICS INC COM APLT APLT 5,567,709 $2.7m0.23% 0.23% ReducedShares held: Q2 2024 9.5m, Q3 2024 9.8m, Q4 2024 10.0m, Q1 2025 5.6m -4.4m -4,422,882 -44.3%
30 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 677,600 $2.2m0.19% 0.19% ReducedShares held: Q2 2024 4.4m, Q3 2024 4.4m, Q4 2024 3.0m, Q1 2025 677.6k -2.3m -2,274,771 -77.0%
31 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 987,259 $2.1m0.18% 0.18% UnchangedShares held: Q2 2024 111.7k, Q3 2024 987.3k, Q4 2024 987.3k, Q1 2025 987.3k
32 TENAX THERAPEUTICS INC COM NEW TENX TENX 208,333 $1.4m0.12% 0.12% UnchangedShares held: Q2 2024 0, Q3 2024 208.3k, Q4 2024 208.3k, Q1 2025 208.3k
33 MERSANA THERAPEUTICS INC COM COM 3,574,325 $1.2m0.10% 0.10% ReducedShares held: Q2 2024 11.3m, Q3 2024 11.3m, Q4 2024 10.3m, Q1 2025 3.6m -6.7m -6,683,465 -65.2%
34 CENTURY THERAPEUTICS INC COM IPSC IPSC 2,498,069 $1.2m0.10% 0.10% ReducedShares held: Q2 2024 5.4m, Q3 2024 5.4m, Q4 2024 4.0m, Q1 2025 2.5m -1.5m -1,459,117 -36.9%
35 TENAYA THERAPEUTICS INC COM TNYA TNYA 1,555,556 $886.8k0.08% 0.08% UnchangedShares held: Q2 2024 1.6m, Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m
36 GLYCOMIMETICS INC COM COM 3,000,000 $630.0k0.05% 0.05% UnchangedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 3.0m, Q1 2025 3.0m
37 INSTIL BIO INC COM NEW TIL TIL 33,177 $576.0k0.05% 0.05% UnchangedShares held: Q2 2024 0, Q3 2024 33.2k, Q4 2024 33.2k, Q1 2025 33.2k

Sold out since Q4 2024

SecurityTickerShares held beforeValue then
MERUS N V MRUS MRUS 592,411 $24.9m592.4k shares
AQUESTIVE THERAPEUTICS INC AQST AQST 2,629,786 $9.4m2.6m shares
TERNS PHARMACEUTICALS INC 1,077,090 $6.0m1.1m shares
TAYSHA GENE THERAPIES INC TSHA TSHA 3,225,180 $5.6m3.2m shares